Youngil Hydrochloride Metformin Tablets 850 mg

Adult dose

The prescribed dosage should be determined based on individual drug effectiveness and tolerance, ensuring not to exceed the recommended maximum daily dose. This medication should be initiated at a low dose to minimize gastrointestinal side effects and ascertain the minimum dose necessary for adequate blood glucose control, administered 500 mg with meals 2 to 3 times a day. Dose increases should be made gradually by 500 mg weekly, up to 20

Child dose

For children aged 10 years and older or adolescents, the usual starting dose is 500 mg once daily taken during or after meals. Blood glucose levels should be measured after one week to adjust the dosage.

This medication can cause serious lactic acidosis or hypoglycemia, which can lead to death, so caution is required. This medication should not be administered to patients with moderate or severe renal impairment, dehydration, severe infections, acute conditions affecting kidney function such as cardiovascular collapse or acute myocardial infarction. Administration is also prohibited for patients with acute or unstable heart failure. Patients scheduled to undergo examinations using iodinated contrast media should discontinue this medication for a certain period before and after the examination, and only resume it after renal function has been confirmed to be normal. Patients with a history of allergic reactions to this medication or similar drugs, patients with type 1 diabetes, patients with metabolic acidosis or a history thereof should not receive this medication. Patients with severe infections or severe traumatic systemic disorders should temporarily discontinue this medication, and resume treatment after orally intakes and renal function have recovered to normal. Patients undergoing surgery should discontinue this medication 48 hours prior to surgery and restart only after confirming normal renal function post-surgery. Caution should be exercised when using this medication in patients with poor nutritional status or weakness, liver dysfunction, severe respiratory function impairment or hypoxia, excessive alcohol intake, dehydration, or gastrointestinal disorders. Pregnant women with placental dysfunction, preeclampsia, or risk of intrauterine growth restriction should not initiate treatment with this medication and should closely monitor fetal development. It is important to maintain regular meals and proper exercise while taking this medication, and to regularly check blood glucose and renal function. If symptoms of lactic acidosis such as malaise, muscle pain, respiratory distress, or abdominal pain occur, medical attention should be sought immediately, and this medication should be discontinued if such symptoms are suspected. This medication may cause gastrointestinal disturbances, especially diarrhea, nausea, vomiting, and abdominal pain upon initial administration, but most are transient. Hypoglycemia is rare with this medication alone but may occur when used in combination with other hypoglycemic agents or when food intake is inadequate, so caution is advised. Elderly patients and those with impaired renal function should have their dosage adjusted and renal function monitored regularly. Alcohol may enhance the effects of this medication on lactate metabolism, so excessive drinking should be avoided during treatment. It is recommended to regularly check vitamin B12 levels while on this medication, and appropriate measures should be taken if deficiency is suspected. This medication can interact with other drugs, so patients should inform their healthcare provider about other medications they are taking, and any changes in blood glucose or abnormal symptoms should be carefully monitored. During pregnancy, this medication can cross the placenta, so those planning to become pregnant or who are pregnant must consult their healthcare provider to determine the appropriate treatment. For breastfeeding mothers, this medication may be secreted into breast milk, so careful consideration of whether to breastfeed and the necessity of drug treatment should be undertaken. This medication can also be used in children and adolescents, but particularly for children aged 10 to 12 years, treatment effects and safety should be closely monitored. In case of overdose, the risk of lactic acidosis increases, so prescribed dosages must be adhered to and immediate medical attention should be sought if overdose is suspected. This medication does not cause weight gain, making it beneficial for diabetic patients who need to manage weight, and long-term use helps in blood glucose control and the prevention of diabetes-related complications.

Serious side effects

Lactic acidosis (muscle pain, respiratory distress, malaise, abdominal pain, low body temperature, low blood pressure, altered consciousness), severe allergic reactions (hives, significant swelling), serious dermatological reactions (severe rash with fever, blisters, skin peeling, mucosal pain), liver abnormalities (jaundice of skin or eyes, generalized fatigue), hypoglycemia, severe edema or urination abnormalities (decreased urine output, generalized swelling, elevated blood pressure)

Mild side effects

Gastrointestinal symptoms (diarrhea, nausea, vomiting, abdominal distension, loss of appetite, dyspepsia, constipation, abdominal pain), unpleasant or metallic taste, rash, anemia, leukopenia, thrombocytopenia, vitamin B12 deficiency, liver function abnormalities, severe delayed hypoglycemia

This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. Additionally, it is important to store it at room temperature between 1 degree and 30 degrees Celsius to maintain its efficacy.

Appearance

White, rectangular film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle